Did you know, there are approximately 50 million people living with dementia in the world, and this number is estimated to rise to 75 million by 2030. The global societal cost of dementia is approximately $1,000,000,000,000 (one trillion dollars) which is projected to double by 2030.
In addition to the challenges posed due to the progressive nature of this condition, clinical diagnoses of dementia are often made past the stage at which preventative strategies could be applied. This introduces extreme challenges to those affected by dementia.
The Memory, Alzheimer’s, and Dementia (MeAD) project, run by a PhD student Terry McGibbon, is focused towards developing a new test which may facilitate a much earlier diagnosis of dementia than currently possible, in turn preserving more memory, sense of self and improving the overall quality of life of individuals living with dementia.
If you are over the age of 18 and would like to take part in the development of this new test to potentially interrupt the progression of dementia, or if you would like to find out more about the project, please e-mail Terry McGibbon on tmcgi001@gold.ac.uk